TOKYO, January 25, 2017 - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that it will make personnel changes, effective April 1, 2017.
【Details of Personnel Changes】
Vice Presidents
Name
New Responsibilities
Current Responsibilities
Shinji Hidaka
Vice President
Deputy General Manager of Marketing & Sales Div. (Marketing & Sales Promotion)
Vice President
Deputy General Manager of Marketing & Sales Div. and Head of Primary Unit
Koichi Nishikawa
Vice President
Deputy General Manager of Marketing & Sales Div. (Overseas Business)
Vice President
Deputy General Manager of Marketing & Sales Div. (Overseas Business) and Department Manager of Marketing & Sales Planning Dept.
Tadahiko Sato
Vice President
Head of Kanto-Minami Regional Management Office
Vice President
Supervisory Branch Manager of Tokyo Branch 1
Please see the PDF file about other personnel changes.
Contact:
For Media
Chugai Pharmaceutical Co., Ltd
Media Relations Group, Corporate Communications Dept.,
Koki Harada
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp
Chugai Pharmaceutical Co. Ltd. published this content on 25 January 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 January 2017 01:11:03 UTC.
Original documenthttp://www.chugai-pharm.co.jp/english/news/detail/20170125100002.html
Public permalinkhttp://www.publicnow.com/view/1CE89754A8F1F574979E4D45590D924DD967BDE8
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
CHUGAI PHARMACEUTICAL CO., LTD 
